nach oben

Erschienen in:

08.03.2019 | Review Article

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

verfasst von: Ibraheem Husain, Saima Zameer, Tushar Madaan, Akram Minhaj, Wasim Ahmad, Asif Iqubaal, Abuzer Ali, Abul Kalam Najmi

Erschienen in: Metabolic Brain Disease | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Today, neurological disorders such as epilepsy, depression, tardive dyskinesia, and stress, and neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, dementia, and Huntington’s disease affect millions of people all over the world. Existing pharmacological interventions do not meet the desired therapeutic benefits for a significant number of patients, and hence, numerous research studies are in progress to find novel therapies for these disorders. Herbal drugs, which have been used in traditional medicine for centuries, are also being explored and scientifically evaluated for the treatment of these neurological disorders. While substantial evidence exists for the antioxidant, anti-inflammatory, anti-hyperlipidemic, and anti-hyperglycemic effects of Emblica officinalis, in vivo and in vitro studies, have also revealed its beneficial therapeutic activities in numerous neurological disorders. These diverse neuroprotective pharmacodynamic actions of E. officinalis corroborated by accumulating evidence in pre-clinical research studies deserve the attention of the scientific community to develop viable pharmacotherapeutic strategies. The present review elaborates upon the latest scientific evidence pertaining to the pharmacological effects of E. officinalis in numerous neurological and neurodegenerative disorders and also gives way for future research in this area.

Akhtar MS, Ramzan A, Ali A, Ahmad M (2011) Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr 62(6):609–616CrossRefPubMed

Akram M, Nawaz A (2017) Effects of medicinal plants on Alzheimer’s disease and memory deficits. Neural Regen Res 12(4):660–670CrossRefPubMedPubMedCentral

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):270–279CrossRefPubMedPubMedCentral

Aquino CCH, Lang AE (2014) Tardive dyskinesia syndromes: current concepts. Parkinsonism Relat Disord 20:S113–S117CrossRefPubMed

Arafa NM, Abdel-Rahman M, El-khadragy MF, Kassab RB (2013) Evaluation of the possible epileptogenic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters. Neurochem Res 38(1):174–185CrossRefPubMed

Ashwlayan VD, Singh R (2011) Reversal effect of Phyllanthus Emblica (Euphorbiaceae) Rasayana on memory deficits in mice. Int J Appl Pharm 3:10–15

Bharathi MD, Thenmozhi AJ (2018) Attenuation of aluminum-induced neurotoxicity by tannoid principles of Emblica officinalis in Wistar rats. Int J Nutr Pharmacol Neurol Dis 8(2):35

Bhattacharya SK, Bhattacharya D, Muruganandam AV (2000a) Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia. Indian J Exp Biol 38(9):945–947PubMed

Bhattacharya A, Ghosal S, Bhattacharya SK (2000b) Antioxidant activity of tannoid principles of Emblica officinalis (Amla) in chronic stress-induced changes in rat brain. Indian J Exp Biol 38(9):877–880PubMed

Biswas K, AK Azad, Sultana T, Khan F, Hossain S, Alam S, Chowdhary R, Khatun Y (2017) Assessment of in-vitro Cholinesterase Inhibitory and Thrombolytic Potential of bark and seed extracts of Tamarindus indica (L.) relevant to the treatment of Alzheimer's disease and clotting disorders. Journal of Intercultural Ethnopharmacology 6(1):115

Brigitta B (2002) Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 4(1):7–20PubMedPubMedCentral

Davis KL, Berger PA, Hollister LE (1976) Tardive dyskinesia and depressive illness. Psychopharmacol Commun 2(2):125–130PubMed

Dehaene S, Naccache L (2001) Towards a cognitive neuroscience of consciousness: basic evidence and a workspace framework. Cognition 79(1):1–37CrossRefPubMed

Dhingra D, Joshi P, Gupta A, Chhillar R (2012) Possible involvement of monoaminergic neurotransmission in antidepressant-like activity of Emblica officinalis fruits in mice. CNS Neurosci Ther 18(5):419–425CrossRefPubMed

Dias D, Atukorala C, Amaratunga NS, Perera B, Karunathilake L (2018) The effects of Emblica officinalis and Tinospora cordifolia herbal treatment on the prognosis of squamous cell carcinoma of the buccal mucosa and tongue. J Oral Maxillofac Surg Med Pathol 30(1):21–29CrossRef

Edwards S, Lawrence MJ, Cable C, Heinrich M (2018) Where do herbal medicines belong? Part 1—an overview of CAM. Lung Cancer 15:05

Fabene PF, Bramanti P, Constantin G (2010) The emerging role for chemokines in epilepsy. J Neuroimmunol 224(1–2):22–27CrossRefPubMed

Golechha M, Bhatia J, Arya DS (2010) Hydroalcoholic extract of Emblica officinalis Gaertn. Affords protection against PTZ-induced seizures, oxidative stress and cognitive impairment in rats. Indian J Exp Biol 48(5):474-8

Golechha M, Bhatia J, Ojha S, Arya DS (2011) Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention. Pharm Biol 49(11):1128–1136CrossRefPubMed

Golechha M, Bhatia J, Arya DS (2012) Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice. J Environ Biol 33(1):95–100PubMed

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS, Group CSW (2017) Revisiting the cholinergic hypothesis in Alzheimer's disease: emerging evidence from translational and clinical research. Alzheimers Dement S1552-5260(17):33719-6

Husain I, Akhtar M, Vohora D, Abdin MZ, Islamuddin M, Akhtar MJ, Najmi AK (2017) Rosuvastatin attenuates high-salt and cholesterol diet induced neuroinflammation and cognitive impairment via preventing nuclear factor KappaB pathway. Neurochem Res 42(8):2404-2416

Husain I, Akhtar M, Shaharyar M, Islamuddin M, Abdin MZ, Akhtar MJ, Najmi AK (2018a) High-salt-and cholesterol diet-associated cognitive impairment attenuated by tannins-enriched fraction of Emblica officinalis via inhibiting NF-kB pathway. Inflammopharmacology 26(1):147–156CrossRefPubMed

Husain I, Akhtar M, Madaan T, Vohora D, Abdin MZ, Islamuddin M, Najmi AK (2018b) Tannins enriched fraction of Emblica officinalis fruits alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2–ARE pathway. Front Pharmacol 9:23CrossRefPubMedPubMedCentral

Hussain S, Singh A, Rahman SO, Habib A, Najmi AK (2018) Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: a meta-analysis of prospective studies. Neurosci Lett 671:120–127CrossRefPubMed

Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A (2011) Age-dependent accumulation of soluble amyloid β (Aβ) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-α (sAPPα) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3β pathway in Alzheimer mouse model. J Biol Chem 286(21):18414–18425CrossRefPubMedPubMedCentral

Justin Thenmozhi A, Dhivyabharathi M, William Raja TR, Manivasagam T, Essa MM (2016a) Tannoid principles of Emblica officinalis renovate cognitive deficits and attenuate amyloid pathologies against aluminum chloride induced rat model of Alzheimer's disease. Nutr Neurosci 19(6):269–278CrossRefPubMed

Justin Thenmozhi A, Dhivyabharathi M, Manivasagam T, Essa MM (2016b) Tannoid principles of Emblica officinalis attenuated aluminum chloride induced apoptosis by suppressing oxidative stress and tau pathology via Akt/GSK-3betasignaling pathway. J Ethnopharmacol 194:20–29CrossRefPubMed

Khan KH (2009) Roles of Emblica officinalis in medicine-a review. Bot Res Int 2(4):218–228

Kosel M, Sturm V, Frick C, Lenartz D, Zeidler G, Brodesser D, Schlaepfer TE (2007) Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res 41(9):801–803CrossRefPubMed

Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature. 455(7215):894–902CrossRefPubMedPubMedCentral

Kumar CP (2013) Effect of Emblica officinalis on stress induced biochemical and psychological changes in mice. Global Journal of Medical research, Veterinary Science and Veterinary Medicine 13(2):25–28

LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-[beta] in Alzheimer’s disease. Nat Rev Neurosci 8(7):499–509CrossRefPubMed

LaPenna P, Tormoehlen LM (2017) The pharmacology and toxicology of third-generation anticonvulsant drugs. J Med Toxicol 13:329–342

Mathew M, Subramanian S (2014) In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of ayurvedic medicinal plants used for cognitive disorders. PLoS One 9(1):e86804CrossRefPubMedPubMedCentral

McGrath CL, Kelley ME, Dunlop BW, Holtzheimer PE III, Craighead WE, Mayberg HS (2014) Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biol Psychiatry 76(7):527–535CrossRefPubMed

Muller T (2015) Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Expert Opin Investig Drugs 24(6):737–742CrossRefPubMed

Muthuraman A, Sood S, Singla SK (2011) The antiinflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology 19(6):327–334CrossRefPubMed

Nain P, Saini V, Sharma S, Nain J (2012) Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. Leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol 142(1):65–71CrossRefPubMed

Noor NA, Aboul Ezz HS, Faraag AR, Khadrawy YA (2012) Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav 24(2):199–206

Obulesu M, Rao DM (2011) Effect of plant extracts on Alzheimer’s disease: an insight into therapeutic avenues. J Neurosci Rural Pract 2(1):56–61CrossRefPubMedPubMedCentral

Parvez MK (2018) Natural or plant products for the treatment of neurological disorders: current knowledge. Curr Drug Metab 19(5):424–428

Patel S, Goyal R (2012) Emblica officinalis Geart.: a comprehensive review on phytochemistry, pharmacology and ethnomedicinal uses. Res J Med Plant 6:6–16CrossRef

Prokai D, Berga SL (2016) Neuroprotection via reduction in stress: altered menstrual patterns as a marker for stress and implications for long-term neurologic health in women. Int J Mol Sci 17(12):2147CrossRefPubMedCentral

Ramakrishna V, Gupta KP, Setty HO, Kondapi KA (2014) Neuroprotective effect of Emblica officinalis extract against H₂O₂ induced DNA damage and repair in neuroblastoma cells. J Homeop Ayurv Med S1002:1

Reddy VD, Padmavathi P, Kavitha G, Gopi S, Varadacharyulu N (2011) Emblica officinalis ameliorates alcohol-induced brain mitochondrial dysfunction in rats. J Med Food 14(1–2):62–68CrossRefPubMed

Sannino G, Pasqualini L, Ricciardelli E, Montilla P, Soverchia L, Ruggeri B, Falcinelli S, Renzi A, Ludka C, Kirchner T et al (2016) Acute stress enhances the expression of neuroprotection- and neurogenesis-associated genes in the hippocampus of a mouse restraint model. Oncotarget 7(8):8455–8465CrossRefPubMedPubMedCentral

Shalini B, Sharma J (2015) Beneficial effects of emblica officinalis on fluoride-induced toxicity on brain biochemical indexes and learning-memory in rats. Toxicol Int 22(1):35–39CrossRefPubMedPubMedCentral

Singh MK, Yadav SS, Gupta V, Khattri S (2013) Immunomodulatory role of Emblica officinalis in arsenic induced oxidative damage and apoptosis in thymocytes of mice. BMC Complement Altern Med 13(1):193CrossRefPubMedPubMedCentral

Singh MK, Dwivedi S, Yadav SS, Sharma P, Khattri S (2014a) Arsenic-induced hepatic toxicity and its attenuation by fruit extract of Emblica officinalis (Amla) in mice. Indian J Clin Biochem 29(1):29–37CrossRefPubMed

Singh MK, Yadav SS, Yadav RS, Singh US, Shukla Y, Pant KK, Khatri S (2014b) Efficacy of crude extract of Emblica officinalis (amla) in arsenic-induced oxidative damage and apoptosis in splenocytes of mice. Toxicol Int 21(1):8–17CrossRefPubMedPubMedCentral

Singh MK, Yadav SS, Yadav RS, Chauhan A, Katiyar D, Khattri S (2015) Protective effect of Emblica-officinalis in arsenic induced biochemical alteration and inflammation in mice. Springerplus. 4:438CrossRefPubMedPubMedCentral

Suomalainen A, Battersby BJ (2017) Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol 19:77–92CrossRefPubMed

Uddin MS, Al Mamun A, Hossain MS, Akter F, Iqbal MA, Asaduzzaman M (2016) Exploring the effect of Phyllanthus emblica L. on cognitive performance, brain antioxidant markers and acetylcholinesterase activity in rats: promising natural gift for the mitigation of Alzheimer’s disease. Ann Neurosci 23(4):218–229CrossRefPubMedPubMedCentral

Vajda FJ (2002) Neuroprotection and neurodegenerative disease. J Clin Neurosci 9(1):4–8CrossRefPubMed

Variya BC, Bakrania AK, Patel SS (2016) Emblica officinalis (Amla): a review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms. Pharmacol Res 111:180–200CrossRefPubMed

Vasudevan M, Parle M (2007a) Effect of Anwala churna (Emblica officinalis GAERTN.): an ayurvedic preparation on memory deficit rats. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan 127(10):1701–1707CrossRefPubMed

Vasudevan M, Parle M (2007b) Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): an Ayurvedic preparation. Physiol Behav 91(1):46–54CrossRefPubMed

Wankhar D, Devi RS, Ashok I (2014) Emblica officinalis outcome on noise stress induced behavioral changes in Wistar albino rats. Biomed Prev Nutr 4(2):219–224CrossRef

Xie T, Wang W-p, Mao Z-f, Qu Z-z, Luan S-q, Jia L-j, Kan M-c (2012) Effects of epigallocatechin-3-gallate on pentylenetetrazole-induced kindling, cognitive impairment and oxidative stress in rats. Neurosci Lett 516(2):237–241CrossRefPubMed

Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu D-C, Juneja LR (2007) Amla (Emblica officinalis Gaertn.) prevents dyslipidemia and oxidative stress in the aging process. Br J Nutr 97(6):1187–1195CrossRefPubMed

Zameer S, Najmi AK, Vohora D, Akhtar M (2017) A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential. Nutr Neurosci 21(8):539-545

Titel: Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review
verfasst von: Ibraheem Husain
Saima Zameer
Tushar Madaan
Akram Minhaj
Wasim Ahmad
Asif Iqubaal
Abuzer Ali
Abul Kalam Najmi
Publikationsdatum: 08.03.2019
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 4/2019
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-019-00400-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Checkpointhemmer auch bei MS sicher

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1

Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca2+ influx and inflammatory cytokine molecular pathways in the docetaxel-treated mice by melatonin and selenium treatments

Magnesium sulfate protects blood–brain barrier integrity and reduces brain edema after acute ischemic stroke in rats

Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations

Schwann cell transplantation exerts neuroprotective roles in rat model of spinal cord injury by combating inflammasome activation and improving motor recovery and remyelination

Electrical stimulation mPFC affects morphine addiction by changing glutamate concentration in the ventral tegmental area

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Checkpointhemmer auch bei MS sicher

Update Neurologie